Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in alzheimer's disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?

  1. Merino, J.J.
  2. Muñetón-Gómez, V.
  3. Alvárez, M.-I.
  4. Toledano-Díaz, A.
Aldizkaria:
Current Alzheimer Research

ISSN: 1875-5828,  1567-2050

Argitalpen urtea: 2016

Alea: 13

Zenbakia: 4

Orrialdeak: 403-412

Mota: Artikulua

DOI: 10.2174/1567205013666151116125714 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus